Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

被引：0
|
作者：
Kevin M. Pantalone
Anita D. Misra-Hebert
Todd M. Hobbs
Xinge Ji
Sheldon X. Kong
Alex Milinovich
Wayne Weng
Janine Bauman
Rahul Ganguly
Bartolome Burguera
Michael W. Kattan
Robert S. Zimmerman
机构：
[1] Cleveland Clinic,Department of Endocrinology, Endocrinology and Metabolism Institute
[2] Cleveland Clinic,Medicine Institute
[3] Cleveland Clinic,Quantitative Health Sciences
[4] Novo Nordisk Inc.,Bariatric and Metabolic Institute
[5] Health Economics and Outcomes Research,undefined
[6] Novo Nordisk Inc.,undefined
[7] Cleveland Clinic,undefined
来源：
Cardiovascular Diabetology | / 17卷
关键词：
Cardiovascular disease; Type 2 diabetes; Population health; Antidiabetic therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Treatment patterns of antidiabetic and kidney protective therapies among patients with type 2 diabetes mellitus and chronic kidney disease in Colombia. The KDICO descriptive study
    Manuel E Machado-Duque
    Andres Gaviria-Mendoza
    Luis F Valladales-Restrepo
    Juan Sebastian Franco
    Maria de Rosario Forero
    David Vizcaya
    Jorge E Machado-Alba
    [J]. Diabetology & Metabolic Syndrome, 15
  • [22] Prescription Patterns of Cardiovascular and Kidney Protective Therapies among Patients with Type 2 Diabetes
    Montealegre, Julio A. Lamprea
    Madden, Erin
    Tummalapalli, Sri Lekha
    Chu, Chi
    Du, Yuxian
    Singh, Rakesh
    Kong, Sheldon
    Tuot, Delphine S.
    Peralta, Carmen
    Shlipak, Michael G.
    Estrella, Michelle
    [J]. DIABETES, 2022, 71
  • [23] Comorbidity Prevalence among Patients with Established Cardiovascular Disease and Type 2 Diabetes
    Iglay, Kristy
    Hannachi, Hakima
    Engel, Samuel S.
    Li, Xueying
    O'Connell, David
    Moore, Lori M.
    Rajpathak, Swapnil
    [J]. DIABETES, 2017, 66 : A404 - A404
  • [24] Comorbidity prevalence among patients with established cardiovascular disease and type 2 diabetes
    Hannachi, H.
    Iglay, K.
    Engel, S. S.
    Li, X.
    O'Connell, D.
    Moore, L. M.
    Rajpathak, S.
    [J]. DIABETOLOGIA, 2017, 60 : S517 - S517
  • [25] BLOOD PRESSURE AND THE RISK OF CARDIOVASCULAR DISEASE AMONG PATIENTS WITH TYPE 2 DIABETES
    Hu, G.
    [J]. CARDIOLOGY, 2014, 128 : 353 - 353
  • [26] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Stuart W. Zarich
    [J]. Nature Reviews Endocrinology, 2009, 5 : 500 - 506
  • [27] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Zarich, Stuart W.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (09) : 500 - 506
  • [28] Evidence for Good Cardiovascular Outcomes among Patients with Type 2 Diabetes, and Promising Treatment for Patients with Type 1 Diabetes
    Ryan, John G.
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (06) : 1274 - 1278
  • [29] Primary and specialty medical care utilization among ethnically diverse, older rural adults with type 2 diabetes: The ELDER diabetes study
    Bell, RA
    Quandt, SA
    Arcury, TA
    Snively, BM
    Stafford, JM
    Smith, SL
    Skelly, AH
    [J]. DIABETES, 2004, 53 : A235 - A235
  • [30] TREATMENT PATTERNS AMONG TYPE 2 DIABETES MELLITUS PATIENTS IN SAUDI ARABIA
    Levy, A. R.
    Szabo, S. M.
    Osenenko, K. M.
    Korol, E. E.
    Qatami, L.
    Al Jaser, S.
    Al Saggabi, A.
    Al Suwaidan, S.
    Maclean, R.
    Donato, B. M. K.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A362 - A362
12345